Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (308) GO Terms (6) Nucleotides (92) Proteins (53) Interactants (177) Wiki
XB-GENEPAGE-1004370

Papers associated with kcnj3



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

The role of RGS protein in agonist-dependent relaxation of GIRK currents in Xenopus oocytes., Sahlholm K., Biochem Biophys Res Commun. November 25, 2011; 415 (3): 509-14.

The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors., Heusler P, Bruins Slot L, Tourette A, Tardif S, Cussac D., Eur J Pharmacol. November 1, 2011; 669 (1-3): 51-8.

Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium., Whorton MR, MacKinnon R., Cell. September 30, 2011; 147 (1): 199-208.

Two distinct aspects of coupling between Gα(i) protein and G protein-activated K+ channel (GIRK) revealed by fluorescently labeled Gα(i3) protein subunits., Berlin S, Tsemakhovich VA, Castel R, Ivanina T, Dessauer CW, Keren-Raifman T, Dascal N., J Biol Chem. September 23, 2011; 286 (38): 33223-35.

Hesperidin induces antinociceptive effect in mice and its aglycone, hesperetin, binds to μ-opioid receptor and inhibits GIRK1/2 currents., Loscalzo LM, Yow TT, Wasowski C, Chebib M, Marder M., Pharmacol Biochem Behav. September 1, 2011; 99 (3): 333-41.

β2-Adrenergic ion-channel coupled receptors as conformational motion detectors., Caro LN, Moreau CJ, Revilloud J, Vivaudou M., PLoS One. March 9, 2011; 6 (3): e18226.            

Inhibition of g protein-activated inwardly rectifying k channels by phencyclidine., Kobayashi T, Nishizawa D, Ikeda K., Curr Neuropharmacol. March 1, 2011; 9 (1): 244-6.    

Identification of selective agonists and antagonists to g protein-activated inwardly rectifying potassium channels: candidate medicines for drug dependence and pain., Nishizawa D, Gajya N, Ikeda K., Curr Neuropharmacol. March 1, 2011; 9 (1): 113-7.      

Agonist-specific voltage sensitivity at the dopamine D2S receptor--molecular determinants and relevance to therapeutic ligands., Sahlholm K, Barchad-Avitzur O, Marcellino D, Gómez-Soler M, Fuxe K, Ciruela F, Arhem P., Neuropharmacology. January 1, 2011; 61 (5-6): 937-49.

Four and a half LIM protein 1C (FHL1C): a binding partner for voltage-gated potassium channel K(v1.5)., Poparic I, Schreibmayer W, Schoser B, Desoye G, Gorischek A, Miedl H, Hochmeister S, Binder J, Quasthoff S, Wagner K, Windpassinger C, Malle E., PLoS One. January 1, 2011; 6 (10): e26524.            

Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants., Kobayashi T, Washiyama K, Ikeda K., PLoS One. January 1, 2011; 6 (12): e28208.            

G protein {beta}{gamma} gating confers volatile anesthetic inhibition to Kir3 channels., Styer AM, Mirshahi UL, Wang C, Girard L, Jin T, Logothetis DE, Mirshahi T., J Biol Chem. December 31, 2010; 285 (53): 41290-9.

Gating of a G protein-sensitive mammalian Kir3.1 prokaryotic Kir channel chimera in planar lipid bilayers., Leal-Pinto E, Gómez-Llorente Y, Sundaram S, Tang QY, Ivanova-Nikolova T, Mahajan R, Baki L, Zhang Z, Chavez J, Ubarretxena-Belandia I, Logothetis DE., J Biol Chem. December 17, 2010; 285 (51): 39790-800.

Intron 4 containing novel GABAB1 isoforms impair GABAB receptor function., Lee C, Lee C, Mayfield RD, Harris RA., PLoS One. November 16, 2010; 5 (11): e14044.            

Identification and characterization of Cs(+) -permeable K(+) channel current in mouse cerebellar Purkinje cells in lobules 9 and 10 evoked by molecular layer stimulation., Ishii H, Nakajo K, Yanagawa Y, Kubo Y., Eur J Neurosci. September 1, 2010; 32 (5): 736-48.

Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist., Heusler P, Rauly-Lestienne I, Tourette A, Tardif S, Ailhaud MC, Croville G, Cussac D., Eur J Pharmacol. August 25, 2010; 640 (1-3): 8-14.

Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells., Ledonne A, Federici M, Giustizieri M, Pessia M, Imbrici P, Millan MJ, Bernardi G, Mercuri NB., Br J Pharmacol. July 1, 2010; 160 (6): 1509-20.

Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine., Kobayashi T, Washiyama K, Ikeda K., Neuropsychopharmacology. June 1, 2010; 35 (7): 1560-9.

Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line., Wagner V, Stadelmeyer E, Riederer M, Regitnig P, Gorischek A, Devaney T, Schmidt K, Tritthart HA, Hirschberg K, Bauernhofer T, Schreibmayer W., J Cell Biochem. June 1, 2010; 110 (3): 598-608.

G alpha(i) and G betagamma jointly regulate the conformations of a G betagamma effector, the neuronal G protein-activated K+ channel (GIRK)., Berlin S, Keren-Raifman T, Castel R, Rubinstein M, Dessauer CW, Ivanina T, Dascal N., J Biol Chem. February 26, 2010; 285 (9): 6179-85.

Further characterization of regulation of Ca(V)2.2 by stargazin., Tselnicker I, Dascal N., Channels (Austin). January 1, 2010; 4 (5): 351-4.

Identification of the structural determinant responsible for the phosphorylation of G-protein activated potassium channel 1 by cAMP-dependent protein kinase., Müllner C, Steinecker B, Gorischek A, Schreibmayer W., FEBS J. November 1, 2009; 276 (21): 6218-26.

Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3., Kobayashi T, Washiyama K, Ikeda K., PLoS One. July 21, 2009; 4 (7): e6311.              

Divergent regulation of GIRK1 and GIRK2 subunits of the neuronal G protein gated K+ channel by GalphaiGDP and Gbetagamma., Rubinstein M, Peleg S, Berlin S, Brass D, Keren-Raifman T, Dessauer CW, Ivanina T, Dascal N., J Physiol. July 15, 2009; 587 (Pt 14): 3473-91.

Heteromeric assembly of inward rectifier channel subunit Kir2.1 with Kir3.1 and with Kir3.4., Ishihara K, Yamamoto T, Kubo Y., Biochem Biophys Res Commun. March 20, 2009; 380 (4): 832-7.

Amplitude histogram-based method of analysis of patch clamp recordings that involve extreme changes in channel activity levels., Yakubovich D, Rishal I, Dessauer CW, Dascal N., J Mol Neurosci. March 1, 2009; 37 (3): 201-11.

Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels., Kobayashi T, Hirai H, Iino M, Fuse I, Mitsumura K, Washiyama K, Kasai S, Ikeda K., Neuropharmacology. February 1, 2009; 56 (2): 499-506.

Activation gating kinetics of GIRK channels are mediated by cytoplasmic residues adjacent to transmembrane domains., Sadja R, Reuveny E., Channels (Austin). January 1, 2009; 3 (3): 205-14.

Differential voltage-sensitivity of D2-like dopamine receptors., Sahlholm K, Marcellino D, Nilsson J, Fuxe K, Rhem P., Biochem Biophys Res Commun. September 26, 2008; 374 (3): 496-501.

Increases in intracellular calcium triggered by channelrhodopsin-2 potentiate the response of metabotropic glutamate receptor mGluR7., Caldwell JH, Herin GA, Nagel G, Bamberg E, Scheschonka A, Betz H., J Biol Chem. September 5, 2008; 283 (36): 24300-7.

Electrophysiology-based analysis of human histamine H(4) receptor pharmacology using GIRK channel coupling in Xenopus oocytes., Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P., Eur J Pharmacol. September 4, 2008; 591 (1-3): 52-8.

Voltage-dependence of the human dopamine D2 receptor., Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P., Synapse. June 1, 2008; 62 (6): 476-80.

Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells., Newman-Tancredi A, Heusler P, Martel JC, Ormière AM, Leduc N, Cussac D., Int J Neuropsychopharmacol. May 1, 2008; 11 (3): 293-307.

Subunit stoichiometry of heterologously expressed G-protein activated inwardly rectifying potassium channels analysed by fluorescence intensity ratio measurement., Grasser E, Steinecker B, Ahammer H, Schreibmayer W., Pflugers Arch. March 1, 2008; 455 (6): 1017-24.

Identification of peptides that inhibit regulator of G protein signaling 4 function., Wang Y, Lee Y, Zhang J, Young KH., Pharmacology. January 1, 2008; 82 (2): 97-104.

Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit., Calloe K, Ravn LS, Schmitt N, Sui JL, Duno M, Haunso S, Grunnet M, Svendsen JH, Olesen SP., Biochem Biophys Res Commun. December 28, 2007; 364 (4): 889-95.

The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes., Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P., Eur J Pharmacol. July 19, 2007; 567 (3): 206-10.

Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes., Kobayashi T, Nishizawa D, Iwamura T, Ikeda K., Toxicol In Vitro. June 1, 2007; 21 (4): 656-64.

Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes., Wedemeyer C, Goutman JD, Avale ME, Franchini LF, Rubinstein M, Calvo DJ., Eur J Pharmacol. May 21, 2007; 562 (3): 165-73.

Galphai3 primes the G protein-activated K+ channels for activation by coexpressed Gbetagamma in intact Xenopus oocytes., Rubinstein M, Peleg S, Berlin S, Brass D, Dascal N., J Physiol. May 15, 2007; 581 (Pt 1): 17-32.

Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels., Heusler P, Newman-Tancredi A, Castro-Fernandez A, Cussac D., Neuropharmacology. March 1, 2007; 52 (4): 1106-13.

Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors., Evaul K, Jamnongjit M, Bhagavath B, Hammes SR., Mol Endocrinol. January 1, 2007; 21 (1): 186-96.

Inhibitory effect of gabapentin on N-methyl-D-aspartate receptors expressed in Xenopus oocytes., Hara K, Sata T., Acta Anaesthesiol Scand. January 1, 2007; 51 (1): 122-8.

The GIRK1 brain variant GIRK1d and its functional impact on heteromultimeric GIRK channels., Steinecker B, Rosker C, Schreibmayer W., J Recept Signal Transduct Res. January 1, 2007; 27 (5-6): 369-82.

RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling., Jaén C, Doupnik CA., J Biol Chem. November 10, 2006; 281 (45): 34549-60.

Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine., Kobayashi T, Washiyama K, Ikeda K., J Pharmacol Sci. November 1, 2006; 102 (3): 278-87.

Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells., Rebois RV, Robitaille M, Galés C, Dupré DJ, Baragli A, Trieu P, Ethier N, Bouvier M, Hébert TE., J Cell Sci. July 1, 2006; 119 (Pt 13): 2807-18.

Base of pore loop is important for rectification, activation, permeation, and block of Kir3.1/Kir3.4., Makary SM, Claydon TW, Dibb KM, Boyett MR., Biophys J. June 1, 2006; 90 (11): 4018-34.

Modulation of basal and receptor-induced GIRK potassium channel activity and neuronal excitability by the mammalian PINS homolog LGN., Wiser O, Qian X, Ehlers M, Ja WW, Roberts RW, Reuveny E, Jan YN, Jan LY., Neuron. May 18, 2006; 50 (4): 561-73.

Effects of the abused inhalant toluene on ethanol-sensitive potassium channels expressed in oocytes., Del Re AM, Dopico AM, Woodward JJ., Dev Biol. May 4, 2006; 1087 (1): 75-82.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 ???pagination.result.next???